Startups
MISSION Therapeutics
https://missiontherapeutics.comDeubiquitylating enzyme (DUB) drug discovery and development platform.
Summary
Industry
Insights
Investors
- Sofinnova Partners Series C
- Roche Venture Fund Series C
- Pfizer Venture Investments Series C
- Sofinnova Partners Series B
- Rosetta Capital Series B
- IP Group Series B
- Roche Venture Fund Series B
- Pfizer Venture Investments Series B
- Sofinnova Partners Series A
- Roche Venture Fund Series A